Search - tctmd.com

Displaying 141 - 160 of 266

Sort: Relevancy | Date

News Opinion Fellow Talk

Pursuing Training in Structural Heart Interventions: Q&A With Mario Gössl, MD

Yashasvi Chugh, MD

August 05, 2019

News Features

Structural Heart Hype: As Fellowship Programs Mushroom, Who’s Keeping Tabs on Quality and Numbers?

Yael L. Maxwell

August 02, 2019

News Daily News

RAS Inhibition After TAVR Gains More Support, but RCT Still Needed

Todd Neale

July 29, 2019

News Daily News

Evolut Valves: Initial Positioning Can Be Optimized for Future Coronary Access

Michael O'Riordan

July 10, 2019

News Conference News TVT 2019

Surgical Risk Should Be ‘Off the Table’ When Deciding on Eligibility for TAVR

Michael O'Riordan

June 19, 2019

News Conference News TVT 2019

PCI During or After TAVR No Riskier Than PCI Before Valve Replacement

Michael O'Riordan

June 13, 2019

News Conference News EuroPCR 2019

Allegra TAVR System Feasible for Treating Degenerated Surgical Valves

Michael O'Riordan

May 29, 2019

CHOICE: Better Hemodynamics, Less Structural Deterioration with CoreValve

News Conference News EuroPCR 2019

Self-Expanding vs Balloon-Expandable TAVR? Some Insights From CHOICE

Michael O'Riordan

May 24, 2019

News Conference News EuroPCR 2019

TAVR’s Benefit Across ‘Spectrum of Risk’ Supports Paradigm Shifts, Says EuroPCR Statement

Shelley Wood

May 23, 2019

News Conference News HRS 2019

PRAGUE-12: Surgical Ablation of A-fib During Cardiac Surgery Has Long-term Stroke Benefit

Todd Neale

May 20, 2019

News Conference News EuroPCR 2019

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

Shelley Wood

May 16, 2019

News Daily News

Could PET Imaging Be the ‘Game Changer’ for Detecting and Predicting Bioprosthetic Valve Degeneration?

Michael O'Riordan

March 13, 2019

News Daily News

New CT Guidelines for TAVR Emphasize Standardization, 4-D Acquisition, and Postprocedural Imaging

Yael L. Maxwell

January 14, 2019

News Daily News

Could RAS-Inhibitor Prescription After TAVR Improve 1-Year Outcomes?

Yael L. Maxwell

December 10, 2018

News Daily News

Mortality Outcomes Similar Whether TAVR Performed in Hybrid OR or Cath Lab

Yael L. Maxwell

November 14, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2018

Shelley Wood

October 02, 2018

News Conference News TCT 2018

PORTICO I: Low 1-Year Mortality With Repositionable TAVR Valve in OUS Experience

L.A. McKeown

September 27, 2018

Top Stories in Cardiology: September 2018

Podcast Heart Sounds

NEOPRO: Two Next-Gen TAVR Valves Show Promise at 30 Days

Yael L. Maxwell

September 25, 2018

News Conference News The Structural Heart Disease Summit 2018

PORTICO I Postapproval Registry Outside the US Offers ‘Teaser’ for Pivotal Trial

Shelley Wood

June 23, 2018

Advertisement

Pursuing Training in Structural Heart Interventions: Q&A With Mario Gössl, MD

Structural Heart Hype: As Fellowship Programs Mushroom, Who’s Keeping Tabs on Quality and Numbers?

RAS Inhibition After TAVR Gains More Support, but RCT Still Needed

Evolut Valves: Initial Positioning Can Be Optimized for Future Coronary Access

Surgical Risk Should Be ‘Off the Table’ When Deciding on Eligibility for TAVR

PCI During or After TAVR No Riskier Than PCI Before Valve Replacement

Allegra TAVR System Feasible for Treating Degenerated Surgical Valves

Self-Expanding vs Balloon-Expandable TAVR? Some Insights From CHOICE

TAVR’s Benefit Across ‘Spectrum of Risk’ Supports Paradigm Shifts, Says EuroPCR Statement

PRAGUE-12: Surgical Ablation of A-fib During Cardiac Surgery Has Long-term Stroke Benefit

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

Could PET Imaging Be the ‘Game Changer’ for Detecting and Predicting Bioprosthetic Valve Degeneration?

New CT Guidelines for TAVR Emphasize Standardization, 4-D Acquisition, and Postprocedural Imaging

Could RAS-Inhibitor Prescription After TAVR Improve 1-Year Outcomes?

Mortality Outcomes Similar Whether TAVR Performed in Hybrid OR or Cath Lab

TCTMD’s Top 10 Most Popular Stories for September 2018

PORTICO I: Low 1-Year Mortality With Repositionable TAVR Valve in OUS Experience

Top Stories in Cardiology: September 2018

NEOPRO: Two Next-Gen TAVR Valves Show Promise at 30 Days

PORTICO I Postapproval Registry Outside the US Offers ‘Teaser’ for Pivotal Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content